We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

171 hedge funds and large institutions have $825M invested in SANGAMO THERAPEUTICS INC in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 58 increasing their positions, 48 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,317% more call options, than puts

Call options by funds: $200M | Put options by funds: $8.28M

59% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 22

21% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 48

11% more capital invested

Capital invested by funds: $742M → $825M (+$83M)

8% more funds holding

Funds holding: 158171 (+13)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
171
Holders Change
+13
Holders Change %
+8.23%
% of All Funds
4.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
58
Reduced
48
Closed
22
Calls
$200M
Puts
$8.28M
Net Calls
+$192M
Net Calls Change
+$4.26M
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
26
Tiverton Asset Management
Delaware
$9.51M
Deutsche Bank
27
Deutsche Bank
Germany
$9.1M +$7.36M +475,695 +453%
First Eagle Investment Management
28
First Eagle Investment Management
New York
$8.78M
UBS AM
29
UBS AM
Illinois
$8.18M -$46.4K -3,000 -0.6%
EAM
30
Eventide Asset Management
Massachusetts
$7.57M
TAM
31
Tocqueville Asset Management
New York
$6.97M +$5.74M +370,800 +502%
CAM
32
Cormorant Asset Management
Massachusetts
$6.93M -$897K -58,000 -12%
CCI
33
Columbus Circle Investors
$6.83M +$4.18M +270,321 +164%
Morgan Stanley
34
Morgan Stanley
New York
$6.78M -$171K -11,070 -2%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$6.45M +$57.7K +3,727 +0.9%
Wellington Management Group
36
Wellington Management Group
Massachusetts
$6.35M +$149K +9,660 +2%
TA
37
Teachers Advisors
New York
$6.33M +$150K +9,670 +2%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$6.29M +$52.2K +3,376 +0.8%
AC
39
Apex Capital
California
$6.27M +$6.19M +400,000 New
Stifel Financial
40
Stifel Financial
Missouri
$6.23M +$6.15M +397,743 New
TCIM
41
TIAA CREF Investment Management
New York
$5.72M +$24.4K +1,574 +0.4%
AGA
42
Altrinsic Global Advisors
Connecticut
$5.33M
Charles Schwab
43
Charles Schwab
California
$5.14M -$51.4K -3,325 -1%
CS
44
Credit Suisse
Switzerland
$5.13M -$762K -49,223 -13%
Asset Management One
45
Asset Management One
Japan
$4.29M +$11.7K +758 +0.3%
Fidelity International
46
Fidelity International
Bermuda
$4.18M +$4.12M +266,418 New
SM
47
Sabby Management
Florida
$4.07M -$522K -33,759 -12%
ACA
48
Avoro Capital Advisors
New York
$3.83M +$3.78M +244,199 New
American Century Companies
49
American Century Companies
Missouri
$3.68M +$1.23M +79,639 +51%
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$3.08M +$590K +38,100 +24%

SGMO Hedge Fund Activity: Q1 2015 in Review

171 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2015, worth a combined $825M — up 11% from $742M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SGMO positions and 22 closed out — a net gain of 13 holders — while 58 added to existing stakes and 48 trimmed.

The largest buyer was Invesco, adding an estimated $14.2M. The largest seller was Adage Capital Partners, cutting an estimated $15.5M.

  • 171 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2015, up from 158 in Q4 2014.
  • Funds reported $825M of SANGAMO THERAPEUTICS INC stock for Q1 2015, up 11% quarter-over-quarter.
  • 35 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2015 and 22 closed out, a net change of +13 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2015 was Invesco, an estimated $14.2M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2015 was Adage Capital Partners, an estimated $15.5M sold.

Based on aggregated 13F filings for Q1 2015.